Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Asthma in adolescents and adults".)
●(See "Society guideline links: Severe asthma in adolescents and adults".)
●(See "Society guideline links: Subacute and chronic cough in adults".)
●(See "Society guideline links: Chronic cough in children".)
International
●Global Initiative for Asthma (GINA): Global strategy for asthma management and prevention, update (2023)
●International Collaboration in Asthma, Allergy, and Immunology (iCAALL): International consensus on (ICON) pediatric asthma (2012)
Canada
●Canadian Paediatric Society (CPS): Position statement for managing an acute asthma exacerbation in children (2021)
●Canadian Thoracic Society (CTS): Guideline for the diagnosis and management of asthma in preschoolers, children, and adults, update (2021)
●Choosing Wisely Canada: Don't initiate medications for asthma (eg, inhalers, leukotriene receptor antagonists, or other) in patients ≥6 years old who have not had confirmation of reversible airflow limitation with spirometry, and in its absence, a positive methacholine or exercise challenge test, or sufficient peak expiratory flow variability (2021)
●Choosing Wisely Canada: Don't use antibiotics for acute asthma exacerbations without clear signs of bacterial infection (2021)
●Choosing Wisely Canada: Don't diagnose or manage current or chronic or persistent asthma in patients >6 years of age without objective testing such as spirometry or a methacholine challenge (2020)
●Canadian Society of Allergy and Clinical Immunology (CSACI): Position statement on systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma (2015)
●CTS and CPS: Position paper for the diagnosis and management of asthma in preschoolers (2015)
United States
●American Academy of Pediatrics (AAP): Clinical report on biologics for asthma and allergic skin diseases in children (2021)
●American Thoracic Society (ATS): An official clinical practice guideline on use of fractional exhaled nitric oxide to guide the treatment of asthma (2021)
●National Heart, Lung, and Blood Institute (NHLBI): A report from the National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC) Expert Panel Working Group – Focused updates to the asthma management guidelines (2020)
•NHLBI and NAEPP: Expert panel report 3 – Guidelines for the diagnosis and management of asthma (2007)
●American Academy of Allergy, Asthma, and Immunology (AAAAI), American College of Allergy, Asthma, and Immunology (ACAAI), and Joint Council of Allergy, Asthma, and Immunology (JCAAI): Management of acute loss of asthma control in the yellow zone – A practice parameter (2014)
●ATS/European Respiratory Society (ERS): An official statement on asthma control and exacerbations – Standardizing endpoints for clinical asthma trials and clinical practice (2009)
●National Environmental Education Foundation (NEEF): Environmental management of pediatric asthma – Guidelines for health care providers (2005)
Europe
●European Respiratory Society (ERS): Clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years (2021)
●ERS: Statement on monitoring asthma in children (2015)
●American Thoracic Society (ATS)/ERS: An official statement on asthma control and exacerbations – Standardizing endpoints for clinical asthma trials and clinical practice (2009)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Guideline on asthma – Diagnosis, monitoring, and chronic asthma management (2017, updated 2021)
●British Thoracic Society (BTS)/Scottish Intercollegiate Guidelines Network (SIGN): British guideline on the management of asthma (2003, revised 2019)
●NICE: Quality standard on asthma (2013, updated 2018)
●NICE: Diagnostic guidance on measuring fractional exhaled nitric oxide concentration in asthma – NIOX MINO, NIOX VERO, and NObreath (2014)
●Royal College of Paediatrics and Child Health (RCPCH): Allergy care pathways for children – Asthma/rhinitis (2011)
Australia–New Zealand
●National Asthma Council Australia (NACA): Australian asthma handbook (2022)
●Choosing Wisely Australia: Do not prescribe antibiotics for exacerbation of asthma (2018)
●Choosing Wisely Australia: Do not prescribe combination therapy (inhaled corticosteroids with long-acting beta2 agonist) as initial therapy in mild to moderate asthma before a trial of inhaled corticosteroids alone (2018)
●Choosing Wisely Australia: Do not use oral beta2 agonists as bronchodilators in asthma, wheeze, or bronchiolitis (2018)
●NACA: Information paper on inhaler techniques for people with asthma or COPD (2018)
●Choosing Wisely Australia: Do not routinely order chest X-rays for the diagnosis of asthma in children (2017)
Japan
●[In English] Japanese Society of Pediatric Allergy and Clinical Immunology (JSPACI) and Japanese Society of Allergology (JSA): Japanese guidelines for childhood asthma (2017)
●[In Japanese] Choosing Wisely Japan: Spirometry test for asthma – Reasons why and if it is necessary (2016)
